A. Brian Jones

Statistics

Publications

Citations

1.6K

H-Index

Active since

1987

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Imperial College London

A. Brian Jones is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and molecular pharmacology.

Publications per year

1987–2010

Publications

Benzoyl 2-methyl indoles as selective PPARγ modulators

John J. Acton, Regina M. Black, A. Brian Jones et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 131 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Functional Properties of the High-Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist (4-Hydroxy-5-iodo-3-methoxyphenylacetate ester) Iodo-Resiniferatoxin

Guy R. Seabrook, Kathy Sutton, Wolfgang Jarolimek et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 128 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux

Carl P. Sparrow, Joanne Baffic, My‐Hanh Lam et al. · Journal of Biological Chemistry · 2002 · 121 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +15

A highly convergent total synthesis of the spiroacetal macrolide (+)-milbemycinβ1

Steven V. Ley, Neville J. Anthony, Alan Armstrong et al. · Tetrahedron · 1989 · 93 citations

Pharmacy, Medicinal Chemistry, Drug Design +10

Discovery of a Potent, Highly Selective, and Orally Efficacious Small-Molecule Activator of the Insulin Receptor

Kun Liu, Libo Xu, Deborah Szalkowski et al. · Journal of Medicinal Chemistry · 2000 · 87 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

1–5 of 33